Efficacy and safety of intravitreal Fluocinolone Acetonide microimplant (ILUVIEN®) in patients with chronic diabetic macular edema: 1 year follow-up.
Fernanda PacellaPacella ElenaEdoardo Trovato BattagliolaMariaelena MalvasiSergio Zaccaria ScalinciPaolo TurchettiMauro SalducciLuca LucchinoLoredana ArricoPublished in: European journal of ophthalmology (2021)
The FAc micro implant has proved efficacy in improving and/or maintaining BVCA in 77% of patients with cDME up to 12 months post-injection. Ocular hypertension is the most common side effect but responds well to topical therapy.